Cargando…
Lung tissue distribution of drugs as a key factor for COVID‐19 treatment
Autores principales: | Wang, Yan, Chen, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276739/ https://www.ncbi.nlm.nih.gov/pubmed/32424836 http://dx.doi.org/10.1111/bph.15102 |
Ejemplares similares
-
Databases for the targeted COVID‐19 therapeutics
por: Wang, Yunxia, et al.
Publicado: (2020) -
Novel approach for low‐dose pulmonary delivery of hydroxychloroquine in COVID‐19
por: Fassihi, Safa C., et al.
Publicado: (2020) -
How Ho Chi Minh City adapted its care pathway to manage the first large-scale community transmission of COVID-19
por: Khue, Luong Ngoc, et al.
Publicado: (2023) -
COVID-19 and Mycobacterium coinfection in Brunei Darussalam: case series
por: Mani, Babu Ivan, et al.
Publicado: (2023) -
Capacity and use of diagnostics and treatment for patients with severe acute respiratory infections in the pre-COVID-19 era in district and provincial hospitals in Viet Nam
por: Dat, Vu Quoc, et al.
Publicado: (2021)